A Prospective, Randomized Trial Comparing the Different Injection Sites of Indocyanine Green (ICG) in Sentinel Lymph Node Mapping in Patients With Endometrial Cancer
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing different method performed in patients with endometrial cancer. The aim of this study is to investigate whether the detection rate of sentinel lymph node (SLN) with two different injection sites may be increased compared to the standard use with single site (cervix) injection in endometrial cancer.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• • 1.Age \>18 and \<80 years old
‣ 2\. The pathological diagnosis was epithelial ovarian cancer
⁃ 3.Survival time is expected to exceed 3 months
⁃ 4.Signed consent form
Locations
Other Locations
China
Qilu Hospital，Shandong University
RECRUITING
Jinan
Contact Information
Primary
Jin Peng, PhD
jin_peng@outlook.com
86-18560088205
Backup
Youzhong Zhang, PhD
zhangyouzhong@vip.sina.com
86-18560081866
Time Frame
Start Date: 2024-10-30
Estimated Completion Date: 2026-01-30
Participants
Target number of participants: 42
Treatments
Active_comparator: sentinel lymph node mapping with One injection site (cervix) group
injecting indocyanine green (ICG) dye Intraoperative in cervix
Experimental: sentinel lymph node mapping with two injection site (cervix-uterus) group
injecting indocyanine green (ICG) dye Intraoperative in cervix and uterus
Related Therapeutic Areas
Sponsors
Leads: Qilu Hospital of Shandong University